中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 41 Issue 5
May  2025
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2025  >  41(5): 927-933

Influence of platelet-albumin-bilirubin score on textbook outcome of patients with hepatocellular carcinoma after hepatectomy

DOI: 10.12449/JCH250519
  • 1a.

    Department of Pancreatic Surgery，West China Hospital，Sichuan University，Chengdu 610041，China

  • 1b.

    Department of Liver Surgery，West China Hospital，Sichuan University，Chengdu 610041，China

  • 2.

    Department of Hepatopancreatobiliary Surgery，Ziyang Central Hospital，Ziyang，Sichuan 641399，China

Research funding:

Natural Science Foundation of Sichuan Province (2024NSFSC0637)

More Information
  • Corresponding author: LI Chuan， lichuan@scu.edu.cn （ORCID： 0000-0001-5450-6961）
  • Received Date: 2024-09-21
  • Accepted Date: 2024-10-23
  • Published Date: 2025-05-25
    Abstract
  •   Objective  To investigate the influence of platelet-albumin-bilirubin （PALBI） score on the textbook outcome （TO） of patients with hepatocellular carcinoma （HCC） after hepatectomy， as well as the association of different PALBI scores before surgery with the achievement of TO after hepatectomy in HCC patients.  Methods  A retrospective analysis was performed for the data of HCC patients who underwent hepatectomy in West China Hospital of Sichuan University and Ziyang Central Hospital from January 2013 to January 2022. TO was defined as no serious complication within 30 days after surgery， no death within 90 days， no rehospitalization within 30 days after discharge， no blood transfusion in the perioperative period， RO resection， and no prolongation of hospital stay. The chi-square test was used for comparison of categorical data between two groups. The univariate and multivariate Logistic regression analyses were used to investigate the influencing factors for the achievement of TO after hepatectomy in HCC patients. The Kaplan-Meier method was used to plot the survival curves of HCC patients， and the Log-rank test was used for comparison.  Results  A total of 3 599 patients were included in this study， among whom 2 369 （65.8%） achieved TO. The multivariate Logistic regression analysis showed that PALBI grade （PALBI grade 2： odds ratio ［OR］=1.562， 95% confidence interval ［CI］： 1.308‍ ‍—‍ ‍1.864， P<0.001； PALBI grade 3： OR=2.216， 95%CI： 1.463‍ ‍—‍ ‍3.359， P<0.001） was an independent risk factor for achievement of TO after surgery in HCC patients. The proportion of patients achieving TO decreased with the increase in PALBI grade. Among the patients with PALBI grade 1， 2 or 3， the patients achieving TO accounted for 70.2%， 54.2%， and 38.4%， respectively （χ2=106.295， P<0.001）. The incidence rate of serious complications within 30 days， the mortality rate of patients within 90 days after hepatectomy， readmission rate within 30 days after discharge， perioperative blood transfusion rate， and the rate of prolonged hospital stay all increased with the increase in PALBI grade （all P<0.05）. For the patients achieving TO， the 1-， 3-， and 5-year relapse-free survival rates were 79.5%， 60.6%， and 51.5%， respectively， and the overall survival rates were 92.1%， 80.0%， and 71.1%， respectively； for those who did not achieve TO， the 1-， 3-， and 5-year relapse-free survival rates were 68.5%， 52.7%， and 46.2%， respectively， and the overall survival rates were 83.3%， 66.0%， and 57.1%， respectively. The patients who achieved TO had significantly better relapse-free survival rate and overall survival rate than those who did not achieve TO （χ2=18.936 and 79.371， both P<0.001）.  Conclusion  Preoperative PALBI grade can affect the achievement of TO after hepatectomy in HCC patients， and it is more difficult for patients with a higher PALBI grade to achieve TO. Preoperative PALBI score can be used to early identify the patients with a high risk of postoperative complications， provide early intervention， and enhance perioperative management， thereby improving the perioperative safety and long-term prognosis of HCC patients after hepatectomy.

     

    • FullText(HTML)
  • loading
    • References(38)
  • [1]
    SAYINER M, GOLABI P, YOUNOSSI ZM. Disease burden of hepatocellular carcinoma: A global perspective[J]. Dig Dis Sci, 2019, 64( 4): 910- 917. DOI: 10.1007/s10620-019-05537-2.
    [2]
    RUMGAY H, ARNOLD M, FERLAY J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040[J]. J Hepatol, 2022, 77( 6): 1598- 1606. DOI: 10.1016/j.jhep.2022.08.021.
    [3]
    D’ASSIGNIES G, FAYARD C, LEITAO H, et al. Liver steatosis assessed by preoperative MRI: An independent risk factor for severe complications after major hepatic resection[J]. Surgery, 2016, 159( 4): 1050- 1057. DOI: 10.1016/j.surg.2015.10.008.
    [4]
    PECQUEUX M, BRÜCKNER F, BOGNER A, et al. Interleukin-8 is superior to CRP for the prediction of severe complications in a prospective cohort of patients undergoing major liver resection[J]. Langenbecks Arch Surg, 2023, 408( 1): 377. DOI: 10.1007/s00423-023-03041-w.
    [5]
    KIM BJ, TZENG CD, COOPER AB, et al. Borderline operability in hepatectomy patients is associated with higher rates of failure to rescue after severe complications[J]. J Surg Oncol, 2017, 115( 3): 337- 343. DOI: 10.1002/jso.24506.
    [6]
    WANG FM, LU JM, YANG T, et al. Perioperative changes in serum transaminase levels: Impact on postoperative morbidity following liver resection of hepatocellular carcinoma[J]. Ann Surg, 2025, 281( 4): 624- 631. DOI: 10.1097/SLA.0000000000006235.
    [7]
    LI LQ, LIANG L, SUN LY, et al. Postoperative morbidity adversely impacts long-term oncologic prognosis following hepatectomy for hepatocellular carcinoma: A multicenter observational study[J]. Eur J Surg Oncol, 2021, 47( 10): 2551- 2560. DOI: 10.1016/j.ejso.2021.04.027.
    [8]
    LIU ZP, YAO LQ, DIAO YK, et al. Association of preoperative body mass index with surgical textbook outcomes following hepatectomy for hepatocellular carcinoma: A multicenter study of 1 206 patients[J]. Ann Surg Oncol, 2022, 29: 4278- 4286. DOI: 10.1245/s10434-022-11721-y.
    [9]
    KOLFSCHOTEN NE, KIEVIT J, GOOIKER GA, et al. Focusing on desired outcomes of care after colon cancer resections; hospital variations in‘textbook outcome’[J]. Eur J Surg Oncol, 2013, 39( 2): 156- 163. DOI: 10.1016/j.ejso.2012.10.007.
    [10]
    Oesophago-Gastric Anastomotic Audit(OGAA) Collaborative. Textbook outcome following oesophagectomy for cancer: International cohort study[J]. Br J Surg, 2022, 109( 5): 439- 449. DOI: 10.1093/bjs/znac016.
    [11]
    BONNET J, SCATTON O, GOUMARD C, et al. Patients’ perceptions of the definition of a textbook outcome following liver transplantation[J]. HPB(Oxford), 2023, 25( 12): 1523- 1530. DOI: 10.1016/j.hpb.2023.07.905.
    [12]
    van ROESSEL S, MACKAY TM, van DIEREN S, et al. Textbook outcome: Nationwide analysis of a novel quality measure in pancreatic surgery[J]. Ann Surg, 2020, 271( 1): 155- 162. DOI: 10.1097/SLA.0000000000003451.
    [13]
    LIU PH, HSU CY, HSIA CY, et al. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era[J]. J Gastroenterol Hepatol, 2017, 32( 4): 879- 886. DOI: 10.1111/jgh.13608.
    [14]
    HE LY, XIA ZJ, ZHANG XY, et al. Tenofovir versus entecavir on the prognosis of hepatitis B-related hepatocellular carcinoma after surgical resection: A randomised controlled trial[J]. Int J Surg, 2023, 109( 10): 3032- 3041. DOI: 10.1097/JS9.0000000000000554.
    [15]
    QI WL, SHEN JY, ZHANG Y, et al. Effects of viral load on tenofovir vs. entecavir efficacy in recurrence prevention of hepatitis B virus-related hepatocellular carcinoma[J]. Chin Med J(Engl), 2023, 136( 19): 2362- 2364. DOI: 10.1097/CM9.0000000000002433.
    [16]
    JOHNSON PJ, BERHANE S, KAGEBAYASHI C, et al. Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach-the ALBI grade[J]. J Clin Oncol, 2015, 33( 6): 550- 558. DOI: 10.1200/JCO.2014.57.9151.
    [17]
    YU JJ, LIANG L, LU L, et al. Association between body mass index and postoperative morbidity after liver resection of hepatocellular carcinoma: A multicenter study of 1,324 patients[J]. HPB(Oxford), 2020, 22( 2): 289- 297. DOI: 10.1016/j.hpb.2019.06.021.
    [18]
    QIU ZC, DAI JL, ZHANG Y, et al. Association of the number of concurrent metabolic syndrome risk factors with textbook outcomes following liver resection for patients with hepatocellular carcinoma: A multicenter study[J]. Ann Surg Oncol, 2025, 32( 1): 399- 407. DOI: 10.1245/s10434-024-16343-0.X
    [19]
    QIN L, LI C, XIE F, et al. Combination of albumin-bilirubin grade and clinically significant portal hypertension predicts the prognosis of patients with hepatocellular carcinoma after liver resection[J]. Biosci Trends, 2021, 15( 1): 41- 49. DOI: 10.5582/bst.2021.01064.
    [20]
    CHEN ZX, CHEN JM, GUO Q, et al. Influencing factors analysis of textbook outcome after hepatectomy for hepatolithiasis[J]. Chin J Dig Surg, 2023, 22( S1): 28- 33. DOI: 10.3760/cma.j.cn115610-20230906-00061.

    陈子祥, 陈江明, 郭旗, 等. 肝胆管结石病肝切除术后教科书式结局的影响因素分析[J]. 中华消化外科杂志, 2023, 22( S1): 28- 33. DOI: 10.3760/cma.j.cn115610-20230906-00061.
    [21]
    LIN GT, CHEN JY, SHANG-GUAN ZX, et al. Robot-assisted versus laparoscopic-assisted gastrectomy among malnourished patients with gastric cancer based on textbook outcome[J]. Surg Endosc, 2024, 38( 5): 2666- 2676. DOI: 10.1007/s00464-024-10769-z.
    [22]
    XU SJ, LIN LQ, CHEN TY, et al. Nomogram for prognosis of patients with esophageal squamous cell cancer after minimally invasive esophagectomy established based on non-textbook outcome[J]. Surg Endosc, 2022, 36( 11): 8326- 8339. DOI: 10.1007/s00464-022-09290-y.
    [23]
    LIU H, DIAO YK, WEI F, et al. Stratifying risk of failure to achieve textbook outcomes among patients undergoing hepatectomy for hepatocellular carcinoma: A multicenter score validation study[J]. Eur J Surg Oncol, 2024, 50( 9): 108477. DOI: 10.1016/j.ejso.2024.108477.
    [24]
    TSILIMIGRAS DI, MEHTA R, MERATH K, et al. Hospital variation in textbook outcomes following curative-intent resection of hepatocellular carcinoma: An international multi-institutional analysis[J]. HPB(Oxford), 2020, 22( 9): 1305- 1313. DOI: 10.1016/j.hpb.2019.12.005.
    [25]
    XU FQ, YE TW, WANG DD, et al. Association of preoperative albumin-bilirubin with surgical textbook outcomes following laparoscopic hepatectomy for hepatocellular carcinoma[J]. Front Oncol, 2022, 12: 964614. DOI: 10.3389/fonc.2022.964614.
    [26]
    KANEKO K, SHIRAI Y, WAKAI T, et al. Low preoperative platelet counts predict a high mortality after partial hepatectomy in patients with hepatocellular carcinoma[J]. World J Gastroenterol, 2005, 11( 37): 5888- 5892. DOI: 10.3748/wjg.v11.i37.5888.
    [27]
    KONDO K, CHIJIIWA Y, OTANI K, et al. Characteristics and surgical outcome of HCC patients with low platelet count[J]. Hepatogastroenterology, 2012, 59( 119): 2269- 2272. DOI: 10.5754/hge10649.
    [28]
    LESURTEL M, RAPTIS DA, MELLOUL E, et al. Low platelet counts after liver transplantation predict early posttransplant survival: The 60-5 criterion[J]. Liver Transpl, 2014, 20( 2): 147- 155. DOI: 10.1002/lt.23759.
    [29]
    ENDO Y, TSILIMIGRAS DI, MUNIR MM, et al. Prognostic significance of postoperative complications for patients with hepatocellular carcinoma relative to alpha-feto protein and tumor burden score[J]. HPB(Oxford), 2024, 26( 8): 998- 1006. DOI: 10.1016/j.hpb.2024.04.013.
    [30]
    QI WL, DAI JL, QIU ZC, et al. Nomogram to predict liver surgery-specific complications for hepatocellular carcinoma: A multicenter study[J]. Eur J Surg Oncol, 2023, 49( 12): 107119. DOI: 10.1016/j.ejso.2023.107119.
    [31]
    MIYATA T, MATSUMOTO T, NAKAO Y, et al. Major postoperative complications are associated with early recurrence of hepatocellular carcinoma following hepatectomy[J]. Langenbecks Arch Surg, 2022, 407( 6): 2373- 2380. DOI: 10.1007/s00423-022-02513-9.
    [32]
    NAKAYAMA H, OKAMURA Y, HIGAKI T, et al. Effect of blood product transfusion on the prognosis of patients undergoing hepatectomy for hepatocellular carcinoma: A propensity score matching analysis[J]. J Gastroenterol, 2023, 58( 2): 171- 181. DOI: 10.1007/s00535-022-01946-9.
    [33]
    PENG T, WANG LM, CUI HY, et al. Impact of perioperative allogeneic blood transfusion on the long-term prognosis of patients with different stage tumors after radical resection for hepatocellular carcinoma[J]. Eur J Surg Oncol, 2021, 47( 3 Pt B): 620- 627. DOI: 10.1016/j.ejso.2020.09.021.
    [34]
    HAYASHI H, SHIMIZU A, KUBOTA K, et al. Combination of sarcopenia and prognostic nutritional index to predict long-term outcomes in patients undergoing initial hepatectomy for hepatocellular carcinoma[J]. Asian J Surg, 2023, 46( 2): 816- 823. DOI: 10.1016/j.asjsur.2022.07.122.
    [35]
    KORNBERG A, KASCHNY L, KORNBERG J, et al. Preoperative prognostic nutritional index may be a strong predictor of hepatocellular carcinoma recurrence following liver transplantation[J]. J Hepatocell Carcinoma, 2022, 9: 649- 660. DOI: 10.2147/JHC.S366107.
    [36]
    PAN JY, CHEN SC, TIAN G, et al. Preoperative albumin-bilirubin grade with prognostic nutritional index predicts the outcome of patients with early-stage hepatocellular carcinoma after percutaneous radiofrequency ablation[J]. Front Med(Lausanne), 2020, 7: 584871. DOI: 10.3389/fmed.2020.584871.
    [37]
    NAGATA S, MAEDA S, NAGAMATSU S, et al. Prognostic nutritional index considering resection range is useful for predicting postoperative morbidity of hepatectomy[J]. J Gastrointest Surg, 2021, 25( 11): 2788- 2795. DOI: 10.1007/s11605-020-04893-z.
    [38]
    HAO Y, XIE F, ZHOU YJ, et al. Neoadjuvant therapy of sequential TACE, camrelizumab, and apatinib for single huge hepatocellular carcinoma(NEO-START): Study protocol for a randomized controlled trial[J]. Trials, 2024, 25( 1): 490. DOI: 10.1186/s13063-024-08340-1.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1619) PDF downloads(34) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return